Second Prenetics Buy in a Month, This Time the IM8 Finance Chief

ISB Research · Interesting · sent to Ultimate members August 26, 2026

A day after the CEO stepped in, the CFO of the IM8 unit just put down $497,700 at $21.55. Two insiders inside 30 days on a small consumer health name is the kind of cluster that carries weight, especially from someone running the numbers on the brand doing the heavy lifting here. The tape is with them, the 8-day crossed above the 20-day two days back, and every timeframe reads buy. One caution: MFI at 76 and RSI near 68 mean you're paying up if you chase, so a spread sold under the CFO's $21.55 gets you paid to wait for a cheaper entry.

Ultimate members received this analysis in real time.